These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 7902481)

  • 1. Venodilation in Raynaud's disease.
    Bedarida G; Kim D; Blaschke TF; Hoffman BB
    Lancet; 1993 Dec; 342(8885):1451-4. PubMed ID: 7902481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced cholinergic cutaneous vasodilation in Raynaud's phenomenon.
    Khan F; Coffman JD
    Circulation; 1994 Mar; 89(3):1183-8. PubMed ID: 8124805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin-converting enzyme inhibition improves venous endothelial dysfunction in chronic smokers.
    Chalon S; Moreno H; Hoffman BB; Blaschke TF
    Clin Pharmacol Ther; 1999 Mar; 65(3):295-303. PubMed ID: 10096262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal responses to endothelial agonists in Raynaud's phenomenon and scleroderma.
    Freedman RR; Girgis R; Mayes MD
    J Rheumatol; 2001 Jan; 28(1):119-21. PubMed ID: 11196511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired cholinergic dilator response of resistance arteries isolated from patients with Raynaud's disease.
    Smith PJ; Ferro CJ; McQueen DS; Webb DJ
    Br J Clin Pharmacol; 1999 May; 47(5):507-13. PubMed ID: 10336574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ascorbic acid improves impaired venous and arterial endothelium-dependent dilation in smokers.
    de Sousa MG; Yugar-Toledo JC; Rubira M; Ferreira-Melo SE; Plentz R; Barbieri D; Consolim-Colombo F; Irigoyen MC; Moreno H
    Acta Pharmacol Sin; 2005 Apr; 26(4):447-52. PubMed ID: 15780194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial dysfunction in human hand veins is rapidly reversible after smoking cessation.
    Moreno H; Chalon S; Urae A; Tangphao O; Abiose AK; Hoffman BB; Blaschke TF
    Am J Physiol; 1998 Sep; 275(3):H1040-5. PubMed ID: 9724311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term estrogen administration improves abnormal endothelial function in women with systemic sclerosis and Raynaud's phenomenon.
    Lekakis J; Mavrikakis M; Papamichael C; Papazoglou S; Economou O; Scotiniotis I; Stamatelopoulos K; Vemmos C; Stamatelopoulos S; Moulopoulos S
    Am Heart J; 1998 Nov; 136(5):905-12. PubMed ID: 9812087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nicotine impairs endothelium-dependent dilatation in human veins in vivo.
    Chalon S; Moreno H; Benowitz NL; Hoffman BB; Blaschke TF
    Clin Pharmacol Ther; 2000 Apr; 67(4):391-7. PubMed ID: 10801248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bradykinin-induced venodilation is not impaired with aging in humans.
    Dachman WD; Ford GA; Hoffman BB; Blaschke TF
    J Gerontol; 1992 Sep; 47(5):M166-70. PubMed ID: 1512432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paradoxically enhanced bradykinin-induced venodilation in young, healthy, short-term smokers.
    Vajo Z; Szekacs B; McDonald MH; Takahashi B; Srivathsan K; Dachman WD
    J Cardiovasc Pharmacol; 1999 Aug; 34(2):316-9. PubMed ID: 10445684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cutaneous vasoconstrictor response to venous stasis is normal in subjects with primary Raynaud's disease.
    Edwards CM; Marshall JM; Pugh M
    Clin Auton Res; 1999 Oct; 9(5):255-62. PubMed ID: 10580877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antihypertensive treatment and endothelium-dependent venodilation in sleep-disordered breathing.
    Duchna HW; Orth M; Schultze-Werninghaus G; Guilleminault C; Stoohs RA
    Sleep Breath; 2006 Sep; 10(3):115-22. PubMed ID: 16607560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of bradykinin-induced venodilation in humans.
    Dachman WD; Ford GA; Blaschke TF; Hoffman BB
    J Cardiovasc Pharmacol; 1993 Feb; 21(2):241-8. PubMed ID: 7679158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ascorbic acid does not improve endothelium-dependent flow-mediated dilatation of the brachial artery in patients with Raynaud's phenomenon secondary to systemic sclerosis.
    Mavrikakis ME; Lekakis JP; Papamichael CM; Stamatelopoulos KS; Kostopoulos ChC; Stamatelopoulos SF
    Int J Vitam Nutr Res; 2003 Feb; 73(1):3-7. PubMed ID: 12690904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial and adrenergic dysfunction in Raynaud's phenomenon and scleroderma.
    Freedman RR; Girgis R; Mayes MD
    J Rheumatol; 1999 Nov; 26(11):2386-8. PubMed ID: 10555897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired endothelium-dependent relaxation in isolated resistance arteries of spontaneously diabetic rats.
    Heygate KM; Lawrence IG; Bennett MA; Thurston H
    Br J Pharmacol; 1995 Dec; 116(8):3251-9. PubMed ID: 8719804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular responses evoked by mild cool stimuli in primary Raynaud's disease: the role of endothelin.
    Edwards CM; Marshall JM; Pugh M
    Clin Sci (Lond); 1999 Jun; 96(6):577-88. PubMed ID: 10334963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response of digital arteries to endothelium dependent and independent vasodilators in patients with Raynaud's phenomenon.
    Singh S; De Trafford JC; Baskerville PA; Martin JF
    Eur J Clin Invest; 1995 Mar; 25(3):182-5. PubMed ID: 7781665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-invasive investigation of endothelium-dependent dilatation of the brachial artery in women with primary Raynaud's phenomenon.
    Ringqvist A; Jonason T; Leppert J; Ringqvist I
    Clin Sci (Lond); 1998 Mar; 94(3):239-43. PubMed ID: 9616257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.